z-logo
open-access-imgOpen Access
PATH-03. Clinically Tractable Outcome Prediction of Group 3/4 Medulloblastoma Based on TPD52 Immunohistochemistry: a Multicohort Study
Author(s) -
Alberto Delaidelli,
Christopher Dunham,
Mariarita Santi,
Gian Luca Negri,
Joanna Triscott,
Olga Zheludkova,
Andrey Golanov,
Marina Ryzhova,
Konstantin Okonechnikov,
Daniel Schrimpf,
Damian Stichel,
David H. Ellison,
Andreas von Deimling,
Marcel Kool,
Stefan M. Pfister,
Vijay Ramaswamy,
Michael D. Taylor,
Andrey Korshunov,
Poul Sorensen
Publication year - 2022
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noac079.587
Subject(s) - medulloblastoma , oncology , medicine , immunohistochemistry , biomarker , multivariate analysis , receiver operating characteristic , biology , bioinformatics , pathology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom